WSM — Williams-Sonoma, Inc.

The fundamental news flow is decisively positive: on 2026-08-26 WSM reported Q2 FY2026 revenue of $1.96B (+6.7% YoY) against ~$1.93B consensus, comparable brand revenue +6.2% (strongest in four years, positive across every brand), GAAP diluted EPS of $2.84 (+42%) and non-GAAP EPS of $2.10 vs $2.08 expected. Management raised FY2026 guidance to $8.17B-$8.37B of revenue (+4.7% to +7.2%) and +4% to +6.5% comps, and Wall Street responded with a wave of target increases (KeyBanc to $270, BofA to $263, RBC to $260, Morgan Stanley to $240; consensus target ~$246-$255 from a $190-$275 range). Tempering that: the stock has given back 7.72% over the past month and 0.52% over the past week as of 2026-09-13, RSI has cooled to 42.83, and the FMP analyst rating breakdown still skews cautious (18 buy / 32 hold / 6 sell, consensus 'Hold'), which looks like post-earnings digestion and multiple discipline rather than any deterioration in the story.

Revenue has genuinely inflected. Year-over-year growth by quarter: -4.3% in the quarter ended 2026-02-01 ($2.357B vs $2.462B), +4.4% in the quarter ended 2026-05-03 ($1.805B vs $1.730B), and +6.7% in the quarter ended 2026-08-02 ($1.960B vs $1.837B) - two consecutive quarters of acceleration, which the guidance raise corroborates. That is a turn, not a blip, though the trailing-twelve-month revenue base is only up ~2.2% ($8.005B vs $7.830B), so the recovery is young. Margins are the counterweight: reported Q2 FY2026 operating income of $448.8M implies a 22.9% operating margin, but management's non-GAAP operating margin was 17.3% versus 17.9% a year earlier, and the $2.84 GAAP vs $2.10 non-GAAP EPS gap (~$0.74/share) shows a meaningful one-off inside the headline quarter. On a like-for-like basis Q1 FY2026 operating margin was 16.2% vs 16.8% a year ago and Q3 FY2025 was 17.0% vs 17.8% - a consistent 60-80bp of annual compression, which management attributes to tariffs peaking in Q2 FY2026. Cash generation remains excellent: TTM free cash flow of $1.346B versus $1.028B a year earlier (flattered by the one-off), no long-term debt, $1.03B of cash and an accruals ratio of -3.66% (cash earnings running ahead of reported net income). Net: top line inflecting up, operating margin drifting down on tariffs, balance sheet and cash conversion pristine.

Expensive versus its own history and versus its growth rate. As of 2026-09-13 the shares at $226.23 carry a trailing P/E of 22.85 on $10.01 of TTM EPS, a PEG of 2.91, price/book of 12.44, price/sales of 3.33 and EV/EBITDA of 14.3x (closer to 15.1x adjusting the Q2 one-off out of the EBITDA base). Against a five-year average P/E of 15.79 and average P/S of 2.16, WSM is at a 45% premium on earnings and a 54% premium on sales relative to its own recent history. Forward math is worse, not better: consensus next-FY EPS of $9.509 sits below the $10.01 trailing figure because the one-off rolls off and tariffs bite, putting the forward P/E at ~23.8x - higher than trailing. The sole thing offering valuation support is cash yield: TTM FCF of $1.346B is a ~5.1% FCF yield, or ~4.7% normalized for the one-off, against a 1.24% dividend yield and a debt-free balance sheet. A 45-54% premium to its own multiple history for a business growing revenue mid-single-digits is a full price; the re-rating is defensible on permanently higher margins (~19% operating vs ~10-12% pre-2020) but leaves little cushion.

The market is paying roughly 24x forward earnings for a business guiding to 4.7-7.2% revenue growth - i.e. it is capitalizing management's claim that the 17-19% operating margin structure is permanent and that share gains in a fragmented home sector are durable. Two ways to read that. Bull case: the comp inflection is real, tariffs peak in Q2 FY2026 and lap out, the FY2027 EPS estimate currently sitting at $9.51 proves too low, and the multiple holds at 20-23x - in which case $226 is roughly fair and the recent 7.7% one-month drawdown is a buying opportunity. Bear case: the Q2 headline beat was one-off inflated ($2.84 GAAP vs $2.10 non-GAAP) and the underlying earnings engine actually grew only ~5%, so a market that starts valuing WSM on non-GAAP numbers at 20x would put fair value closer to $190-$200. The tell will be whether non-GAAP operating margin stops compressing at ~17% and whether the FY2027 EPS estimate starts to move up from $9.51 - if it stays anchored, the stock is priced for growth that hasn't shown up yet; if it lifts, the multiple is defensible.

Range-bound consolidation inside a longer uptrend. As of 2026-09-13, RSI(14) stood at 42.83 - neutral and leaning soft, but well short of oversold, so there is no mechanical buy signal here. The price is 2.7% below the 20-day SMA and 2.52% below the 50-day SMA, yet 10.16% above the 200-day SMA (which implies a 200-day level near $205). Return profile: -0.52% over one week, -7.72% over one month, +1.2% over three months, +25.69% over six months - a strong six-month advance now digesting. The 52-week range is $165.51-$254.89, so at $226.23 the stock sits roughly 11% below its high and 37% above its low. Implication: no urgency to chase. The actionable zone is a retest of the 200-day near ~$205, ideally with RSI in the low-to-mid 30s; a clean break and hold above $255 would signal the consolidation is resolved upward and would validate the analyst targets, but buying the middle of the range at a neutral RSI offers a poor entry-timing edge.

• Mortgage rates and the frozen existing-home-sales market: large-ticket furniture demand is tied to housing turnover, and the sector slump persists. WSM has been bucking it via affluent-customer resilience, but a sustained freeze caps the size of the comp recovery.
• Tariffs on imported home goods: management explicitly identified Q2 FY2026 as the peak period of merchandise-margin pressure. Whether that cost is priced through or absorbed determines whether the 17-19% operating margin band holds or erodes.
• Premium consumer health / K-shaped spending: WSM's core customer is affluent and has held up, but any labor-market softening or equity-market drawdown would hit discretionary big-ticket purchases quickly given the 1.46 beta.
• Interest-rate path and rate-cut expectations: an easing cycle would be a double tailwind - thawing housing turnover and supporting high-multiple consumer-discretionary names - while a hawkish repricing would pressure both the demand outlook and the multiple.
• Competitive intensity in home furnishings (RH, Arhaus, Wayfair, Amazon) and retail-sector rotation: WSM is being framed as a structural share gainer, but a promotional environment or import-price competition could reverse the comp trajectory it just established.

• Q3 FY2026 earnings, expected late November 2026 - the key test of whether the +6.2% comp and the raised $8.17B-$8.37B / +4%-6.5% comp guidance hold up, and whether non-GAAP operating margin stabilizes near 17% as tariff costs lap.
• Holiday Q4 sell-through and any further upward revision to FY2026 guidance or initial FY2027 framing.
• Fed rate cuts that unfreeze existing-home sales - the single biggest unlock for deferred big-ticket home-furnishing demand.
• Analyst estimate revisions: specifically whether the $9.509 next-FY EPS consensus starts to move higher after the guidance raise, which would mechanically lower the forward P/E.
• Continued capital returns funded out of $1.03B of cash, zero long-term debt and ~$1.35B of TTM free cash flow (1.24% dividend yield plus buybacks).

• Valuation risk is the first-order risk: 22.85x trailing and ~23.8x forward against a 15.79x five-year average and 2.91 PEG leaves no room for a miss - multiple compression alone could take 20-25% off the price without any change in the business.
• Tariff cost stickiness: management called Q2 the peak, but if landed-cost inflation persists past the lap, the margin structure that justifies the current multiple is what breaks.
• Housing cyclicality: with TTM revenue up only ~2.2% and the existing-home market still depressed, WSM is dependent on a macro thaw it does not control; a further leg down in housing would expose the comp recovery as narrow.
• Earnings quality optics: a $0.74 GAAP-versus-non-GAAP EPS gap in Q2 FY2026 means the headline 42% EPS growth and 22.9% reported operating margin materially overstate the underlying run-rate (~17.3% non-GAAP operating margin, ~5% underlying EPS growth). A market refocusing on adjusted numbers would re-rate the stock lower.
• High beta (1.46) and consumer-discretionary exposure: WSM will underperform sharply in any broad risk-off or recession scenario, and analyst targets are unusually dispersed ($190 low to $275 high), signalling genuine disagreement about fair value.

Williams-Sonoma is a genuinely high-quality retailer - 28.8% ROIC, no long-term debt, $1.03B of cash, negative accruals, ~47% gross margin and ~$1.35B of TTM free cash flow - and it just printed its strongest comps in four years with a raised outlook. But at $226.23 you are paying ~23.8x forward earnings and ~3.3x sales versus a 15.8x / 2.16x five-year average for a business growing revenue mid-single-digits and reporting operating-margin compression of 60-80bps a year on tariffs, with a one-off flattering the Q2 headline. Good business, full price: the risk/reward is not compelling here, and the better entry is a retest of the 200-day moving average near ~$205 (or below) with RSI in the 30s. I would want to see non-GAAP operating margin stop compressing and the $9.51 FY2027 EPS consensus start moving up before treating the current multiple as earned.

Blended two-method estimate as of 2026-09-13: 60% weight on 20.0x forward consensus EPS of $9.51 - a premium to the 15.79x five-year average justified by structurally higher margins (19%+ operating vs ~10-12% pre-2020) and 28.8% ROIC, but a discount to the current ~23.8x forward for housing cyclicality and tariff uncertainty - giving ~$190; plus 40% weight on normalized free cash flow of ~$1.26B (TTM $1.346B less roughly $90M of after-tax one-off benefit) capitalized at a 5.0% target FCF yield on 117.7M shares, giving ~$213. The 60/40 blend lands at ~$199, roughly 12% below the 2026-09-13 price of $226.23 and below the $246-$255 analyst consensus.